Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
A comparison of intermittent pulsed cyclophosphamide to daily oral cyclophosphamide for the
treatment of ANCA-associated systemic vasculitides with kidney involvement.
Performed by the European Vasculitis Study group.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust